Search
Lonicera confusa flower
go.drugbank.com/drugs/DB14344InvestigationalLonicera confusa flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Platycodon grandiflorus root
go.drugbank.com/drugs/DB14347InvestigationalPlatycodon grandiflorus root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Citrus junos fruit
go.drugbank.com/drugs/DB14348InvestigationalCitrus junos fruit is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Platycodon grandiflorus leaf
go.drugbank.com/drugs/DB14356InvestigationalPlatycodon grandiflorus leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Ilex paraguariensis leaf
go.drugbank.com/drugs/DB14366InvestigationalIlex paraguariensis leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Melaleuca alternifolia leaf
go.drugbank.com/drugs/DB14372InvestigationalMelaleuca alternifolia leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Camphor leaf oil
go.drugbank.com/drugs/DB14378InvestigationalCamphor leaf oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Vosoritide
go.drugbank.com/drugs/DB11928ApprovedInvestigational[L39229] It was approved for use under the brand name Voxzogo (BioMarin Pharmaceutical Inc.) in the EU in August 2021 and the US in November 2021,[L39245,L39241] becoming the first pharmacological intervention
Erlotinib
go.drugbank.com/drugs/DB00530ApprovedInvestigationalErlotinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase that is used in the treatment of non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is typically marketed under the...
Golimumab
go.drugbank.com/drugs/DB06674ApprovedInvestigationalThe FDA label includes a black box warning of serious infections and malignancy. Additionally in children and adolescents taking golimumab, there have been lymphoma and other malignancies observed. … Thus golimumab is indicated for use in adults (i) as an adjunct to methotrexate treatment in patients with moderate to severe active rheumatoid arthritis (RA), (ii) alone or as an adjunct to methotrexate
Products: SIMPONI 50MG ILO I E FER